We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Questionnaires of Tumor Patients With and Without Additive Homeopathic Therapy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00861432
First Posted: March 13, 2009
Last Update Posted: September 13, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Michael Frass, Medical University of Vienna
  Purpose
Tumor patients receiving conventional tumor therapies are included into this study. The patients are randomized into two groups receiving either additive homeopathic therapy or not. Two questionnaires referring to subjective feeling and life quality are filled out by the patients with each visit to the outpatients Department. One of them is the QLQC30 questionnaire of the EORTC. The results of the questionnaires of the two groups are compared.

Condition Intervention Phase
Tumor Other: additive homeopathic treatment Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Evaluation of Quality of Life of Tumor Patients With and Without Additive Homeopathy.

Further study details as provided by Michael Frass, Medical University of Vienna:

Primary Outcome Measures:
  • Difference with regard to subjective feeling and life quality with or without homeopathic treatment [ Time Frame: 3 months ]

Enrollment: 400
Study Start Date: December 2008
Study Completion Date: April 2011
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: additive homeopathic treatment
These patients receive additive homeopathic treatment during conventional cancer treatment.
Other: additive homeopathic treatment
These patients receive additive homeopathic treatment
Other Name: homeopathic remedies according to the Pharmacopoeia
No Intervention: no additive homeopathic treatment
These patients do not receive additive homeopathic treatment during conventional cancer treatment.

Detailed Description:
Quality of life is an important issue for cancer patients, especially during the periods of chemotherapy and radiation. Preliminary results have revealed positive effects of add-on homeopathy on quality of life as well as subjective well-being. Patients are receiving classical homeopathy with administration of either globules and/or dilutions. With each appointment, patients complete two questionnaires.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Tumor patients between 18 and 100 years old

Exclusion criteria: Patients younger than 18 years, patients having completed less than 3 questionnaires.

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00861432


Locations
Austria
Med. Univ. Vienna, Dept. Internal Med. I
Vienna, Austria, A1090
Sponsors and Collaborators
Medical University of Vienna
Investigators
Principal Investigator: Michael Frass, MD Medical University Vienna
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Michael Frass, Prof. Dr., Medical University of Vienna
ClinicalTrials.gov Identifier: NCT00861432     History of Changes
Other Study ID Numbers: 2341
First Submitted: March 12, 2009
First Posted: March 13, 2009
Last Update Posted: September 13, 2016
Last Verified: September 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Michael Frass, Medical University of Vienna:
Life quality
questionnaire
tumor patients


To Top